California Approves $5 Million Behavioral Health Pilot to Expand Mental Health Care Across the Central Coast California is taking another step toward strengthening its behavioral health system with a targeted…
Elevance Health Study Raises Concerns Over No Surprises Act Payment Dispute Process for Planned Medical Procedures A new study from the Elevance Health Public Policy Institute is drawing attention to…
Health Experts Urge BC and Alberta to Expand Universal Infant RSV Protection Ahead of Next Respiratory Season A coalition of medical experts is calling on the governments of British Columbia…
Guardant Health Secures FDA Approval for Guardant360 CDx as Companion Diagnostic for Boehringer Ingelheim’s HERNEXEOS® Guardant Health, Inc., a leading precision oncology company, today announced that the U.S. Food and…
Eli Lilly and Company Issues Open Letter Warning About Potential Patient Safety Risks of Tirzepatide Compounded with Vitamin B12 Lilly is issuing a public warning about potential safety risks associated…
Planet DDS 2026 Dental Outlook Shows More New Patients, Fewer No-Shows Across the Industry Planet DDS, a leading provider of cloud-based, enterprise-grade dental software solutions, announced the release of its 2026…
National Kidney Foundation to Honor Dallas Nephrology Associates with 2026 Award Dallas Nephrology Associates (DNA) has been selected to receive the prestigious Burl Osborne Award at the 2026 Bonne Santé…
First Patient Dosed in Emalex Biosciences’ Expanded Access Program for Investigational Tourette Syndrome Therapy Emalex Biosciences today announced that the first patient was dosed in its Expanded Access Program for…
Five Global Teams Awarded $125 Million to Take on the Toughest Challenges at the Frontiers of Cancer Science Cancer Grand Challenges, a global initiative co-founded by the National Cancer Institute…
AN2 Therapeutics, Inc. Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing innovative small molecule therapeutics…
Positive Phase 3 Trial Results Signal New Standard of Care for Bladder Cancer Patients Is the current standard of care for muscle-invasive bladder cancer (MIBC) about to change? Pfizer Inc.…
TAEUS® Demonstrates High Reliability in Clinical Study, Addressing Critical Diagnostic Needs Why is the early detection and monitoring of steatotic liver disease (SLD) so challenging? ENDRA Life Sciences Inc. a…